|
UC Davis Researchers Identify A Cellular Pathway That Makes Prostate Cancer Fatal
Expanding evidence that tiny strands of RNA - called microRNAs - play big roles in the progress of some cancers, UC Davis researchers have identified one that helps jump start prostate cancer cell growth midway through the disease process, eventually causing it to become fatal. The discovery is an important link to finding new treatments targeting this cellular function and reducing cancer deaths among American men. [click link for full article]
PSA test in obese men can produce false results
Scientists in the United States suggest a blood test widely used to screen for prostate cancer can be misleading in the case of men who are obese.
Why Obese Men Post Lower PSA Levels (HealthDay)
HealthDay - TUESDAY, Nov. 20 (HealthDay News) -- In recent years, doctors
have learned that they need to adjust the results of blood tests to
properly diagnose prostate cancer in obese men, but now researchers think
they know why.
Obesity can skew key prostate cancer test results (Reuters)
Reuters - Doctors reading the results of a
blood test widely used to screen for prostate cancer can be
fooled into thinking obese men are disease-free, researchers
said on Tuesday.
Obesity-linked high blood volumes render PSA prostate cancer test less effective, study suggests
The extra blood volume produced in the obese may so dilute levels of a telltale protein produced by prostates that the popular PSA test may be essentially useless for diagnosing prostate cancer in men carrying extra pounds, a new study in the Journal of the American Medical Association suggests.
Obesity associated with lower PSA levels in men with prostate cancer
Higher body mass index is associated with higher plasma volume, which may be related to lower prostate-specific antigen levels among obese men, according to a study in the Nov. 21 issue of JAMA.
Obesity-linked High Blood Volumes Render PSA Prostate Cancer Test Less Effective
The extra blood volume produced in the obese may so dilute levels of a telltale protein produced by prostates that the popular PSA test may be essentially useless for diagnosing prostate cancer in men carrying extra pounds, a new study in The Journal of the American Medical Association suggests.
Obesity Associated With Lower PSA Levels in Men With Prostate Cancer
Higher body mass index (BMI) is associated with higher plasma volume, which may be related to lower prostate-specific antigen (PSA) levels among obese men, according to a study in the November 21 issue of JAMA.
Prostate Cancer Treatment - Clinical Trials
Prostate Cancer Treatment - Clinical Trials Nov 17th, 2007 by Brandon Prostate Cancer Treatment Centre Receives Funding for Clinical Trials Clinical Trial Aimed to Supplement Current Research Findings on the Treatment of Localized Prostate Cancer TORONTO, Nov. 14 /PRNewswire/ A Canadian study on High Intensity Focused Ultrasound therapy with the Sonablate(R) 500 - a Health Canada approved treatment for localized prostate cancer - is underway at Can-Am HIFU. Through funding from Astra
New Prostate Cancer Technology Saving Lives
New Prostate Cancer Technology Saving Lives Nov 17th, 2007 by Brandon SARASOTA, Fla., Nov. 5 /PRNewswire/ JM, a 71 year old business executive from Tennessee, had a negative biopsy using gray scale ultrasound despite a PSA of 7.1. The following year, the PSA rose to 11.5 prompting a second biopsy that was negative despite adding Color Flow Doppler Ultrasound. At this point, the patient and all doctors in attendance were frustrated without a clear path to identify a disease process t
|
